A Covid 19 Case Report complicated with respiratory failure and retroperitoneal hematoma

By, Dr. Sc. Esmeralda META, MD. Afrim YZEIRI, MD. Stavri LLAZO, MD. Elona NAQELLARI, MD. Jonela BURIMI, MD. Dejvi HAXHIAJ, Dr. Sc. Eva DURAKU, MD. Deniona NUNCI, MD. Nikolin MITROLLARI, MD. Endri KATRO

Abstract
Introduction: The Covid 19 pandemic confronted us with a series of multidisciplinary pathologies, beginning with the virus and followed by a cascade of SIRS and multiorgan failure. During the treatment therapy of antivirals, anticoagulants, corticosteroids and antibiotics, we also encounter medications’ interactions. Method: We described a case report of a 74-year-old man, who during the course of hospitalization had several complications. Results: He developed respiratory failure, delirium, SIRS, as well as retroperitoneal hematoma (HRP) as a complication of anticoagulant therapy. It was followed by hemorrhagic shock, respiratory distress and the patient was submitted under mechanical ventilation with step-by-step resuscitation. The patient made clinical and laboratory improvement by being extubated and thereafter was rehabilitated pulmonary and physically. On the 42nd day of hospitalization the patient was discharged from the hospital. Pulmonary and locomotor rehabilitation of the patient was established 2-3 weeks after hospital discharge. Conclusion: Establishing a retroperitoneal hematoma diagnosis requires clinical intuition. Some signs which can raise an alert for a retroperitoneal hematoma can be hypotension, tachypnea and back and abdominal pain in patients who are under anticoagulant therapy.

Key Words: Covid 19, complications, retroperitoneal hematoma.

https://doi.org/10.58944/xmta4019